The aldose reductase inhibitor siteKADOR, P. F; KINOSHITA, J. H; SHARPLESS, N. E et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 109-113, issn 0026-0495, suppl. 1Conference Paper

KINETICS OF AN ORALLY ABSORBED ALDOSE REDUCTASE INHIBITOR, SORBINILFOULDS G; O'BRIEN MM; BIANCHINE JR et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 30; NO 5; PP. 693-700; BIBL. 22 REF.Article

Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosisPING XIE; LIN SUN; OATES, Peter J et al.American journal of physiology. Renal physiology. 2010, Vol 67, Num 6, issn 1931-857X, F1393-F1404Article

The effect of aldose reductase and its inhibition on sugar cataract formationKADOR, P. F; AKAGI, Y; KINOSHITA, J. H et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 15-19, issn 0026-0495, suppl. 1Conference Paper

Aldose reductase inhibition and the diabetic syndrome of limited joint mobility: implications for altered collagen hydrationEATON, R. P.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 119-121, issn 0026-0495, suppl. 1Conference Paper

Clinical experience with sorbinil ― an aldose reductase inhibitorPITTS, N. E; VREELAND, F; SHAW, G. L et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 96-100, issn 0026-0495, suppl. 1Conference Paper

The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesisHONG-MING CHENG; GONZALEZ, R. G.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 10-14, issn 0026-0495, suppl. 1Conference Paper

Applicability of red blood cell sorbitol measurements to monitor the clinical activity of sorbinilPETERSON, M. J; PAGE, M. G; JUST, L. J et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 93-95, issn 0026-0495, suppl. 1Conference Paper

Clinical trials of sorbinil on nerve functionPFEIFER, M. A.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 78-82, issn 0026-0495, suppl. 1Conference Paper

The polyol pathway, sorbinil, and renal dysfunctionBEYER-MEARS, A.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 46-54, issn 0026-0495, suppl. 1Conference Paper

Aldose and aldehyde reductase in animal tissuesFLYNN, T. G.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 105-108, issn 0026-0495, suppl. 1Conference Paper

Proceedings/The effects of sorbinil on the pathophysiology of diabetic complications. Pfizer Sorbinil symposium, Dorado, Puerto Rico, May 30-June 2, 1985PAGE, M. G; HUTSON, N. J.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, issn 0026-0495, 121 p., suppl. 1Conference Proceedings

Evidence for the role of the polyol pathway in the pathophysiology of diabetic complicationsBEYER, T. A; HUTSON, N. J.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 1-3, issn 0026-0495, suppl. 1Conference Paper

High-performance liquid chromatographic analysis of glucose, fructose, sorbitol and low levels of the aldose reductase inhibitor sorbinil in human lens and plasmaLLOYD, P; CRABBE, M. J. C.Journal of chromatography. 1985, Vol 343, Num 2, pp 402-406, issn 0021-9673Article

Synthesis of novel benzoic acid derivatives with benzothiazolyl subunit and evaluation as aldose reductase inhibitorsRAKOWITZ, Dietmar; HENNIG, Barbara; NAGANO, Marietta et al.Archiv der Pharmazie (Weinheim). 2005, Vol 338, Num 9, pp 411-418, issn 0365-6233, 8 p.Article

The aldose reductase inhibitor sorbinil does not prevent the impairment in nitric oxide-mediated neurotransmission in anococcygeus muscle from diabetic ratsWAY, K. J; REID, J. J.European journal of pharmacology. 1996, Vol 318, Num 1, pp 101-108, issn 0014-2999Article

Effect of sorbinil and ascorbic acid on myo-inositol transport in cultured rat Schwann cells exposed to elevated extracellular glucoseKARIHALOO, A. K; JOSHI, K; CHOPRA, J. S et al.Journal of neurochemistry. 1997, Vol 69, Num 5, pp 2011-2018, issn 0022-3042Article

Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with SorbinilO'HARE, J. P; MORGAN, M. H; ALDEN, P et al.Diabetic medicine. 1988, Vol 5, Num 6, pp 537-542, issn 0742-3071Article

Effect of sorbinil on myo-inositol metabolism in cultured neuroblastoma cells exposed to increased glucose levelsYOREK, M. A; DUNLAP, J. A; GINSBERG, B. H et al.Journal of neurochemistry. 1988, Vol 51, Num 2, pp 331-338, issn 0022-3042Article

Proceedings/Symposium on aldose reductase inhibition and late, complications of diabetes. International diabetes federation polyol pathway workshop, Madrid 23 September 1985WARD, J. D; BENFIELD, P. Ed.Drugs (Basel). 1986, Vol 32, issn 0012-6667, 55 p., suppl. 2Conference Proceedings

A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathyArchives of ophthalmology (1960). 1990, Vol 108, Num 9, pp 1234-1244, issn 0003-9950, 11 p.Article

The polyol pathway and glucose 6-phosphate in human endothelial cells cultured in high glucose concentrationsLORENZI, M; TOLEDO, S; BOSS, G. R et al.Diabetologia (Berlin). 1987, Vol 30, Num 4, pp 222-227, issn 0012-186XArticle

Effects of the aldose reductase inhibitor sorbinil on the isolated cultured rat lensLI-AN YEH; RAFFORD, C. E; BEYER, T. A et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 4-9, issn 0026-0495, suppl. 1Conference Paper

Evaluation of some cytological and biochemical effects of sorbinil in miceQURESHI, S; AL-HARBI, M. M; AHMED, M. M et al.Medical science research. 1993, Vol 21, Num 5, pp 191-192, issn 0269-8951Article

Diabetes-induced increases in vascular permeability and changes in granulation tissue levels of sorbitol, myo-inositol, chiro-inositol, and scyllo-inositol are prevented by sorbinilWILLIAMSON, J. R; CHANG, K; ROWOLD, E et al.Metabolism, clinical and experimental. 1986, Vol 35, Num 4, pp 41-45, issn 0026-0495, suppl. 1Conference Paper